NCT02939560View on ClinicalTrials.gov

TMS for Adults With Autism and Depression

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

June 1, 2018

Study Completion Date

September 20, 2018

Conditions
Autism Spectrum DisorderDepressionDepressive DisorderMajor Depressive Disorder
Interventions
DEVICE

NeuroStar® TMS device (Neuronetics, Atlanta, GA)

Participants in this study arm will be evaluated before and after receiving rTMS. Outcome measures will include social skills rating scales, depression rating scales and cognitive tasks while undergoing functional magnetic resonance imaging (fMRI).

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT02939560 - TMS for Adults With Autism and Depression | Biotech Hunter | Biotech Hunter